[1] 宁丰,王景文,杨磊,等.HLA单倍体相合异基因造血干细胞移植后植入综合征一例并文献复习[J].白血病·淋巴瘤,2009,18(7):415-416,418.DOI:10.3760/cma.j.issn.1009-9921.2009.07.010.
[2] 葛群芳,王怡,欧阳桂芳.血液系统疾病造血干细胞移植术后并发植入综合征诊疗分析[J].中国实用内科杂志,2020,40(7):580-585.DOI:10.19538/j.nk2020070113.
[3] Ding Q, Wang Y, Yang C, et al. Clinical utility of the sivelestat for the treatment of ALI/ARDS: moving on in the controversy?[J]. Intensive Care Res, 2023,3(1):12-17. DOI: 10.1007/s44231-022-00012-5.
[4] 中国研究型医院学会危重医学专业委员会,中国医药教育协会重症医学专业委员会.西维来司他钠临床应用专家共识[J].中国研究型医院,2022,9(1):9-13.DOI:10.19450/j.cnki.jcrh.2022.01.003.
[5] 娄瑞,许兰平,张晓辉,等.血液病患者同基因造血干细胞移植后植入综合征的发生率及临床特征[J].中华血液学杂志,2023,44(4):289-294.DOI:10.3760/cma.j.issn.0253-2727.2023.04.005.
[6] Chen Y, Xu LP, Liu KY, et al. High incidence of engraftment syndrome after haploidentical allogeneic stem cell transplantation[J]. Eur J Haematol, 2016, 96(5):517-526. DOI: 10.1111/ejh.12629.
[7] Grant A, Chapman LRM, Mitchell R, et al. Engraftment syndrome following hematopoietic stem cell transplant: a review of the literature[J]. Clin Transplant, 2020, 34(6):e13875. DOI: 10.1111/ctr.13875.
[8] Konuma T, Kohara C, Watanabe E, et al. Cytokine profiles of pre-engraftment syndrome after single-unit cord blood transplantation for adult patients[J]. Biol Blood Marrow Transplant, 2017, 23(11):1932-1938. DOI: 10.1016/j.bbmt.2017.07.020.
[9] Shah NN, Watson TM, Yates B, et al. Procalcitonin and cytokine profiles in engraftment syndrome in pediatric stem cell transplantation[J]. Pediatr Blood Cancer, 2017, 64(3):10.1002/pbc.26273. DOI: 10.1002/pbc.26273.
[10] 刘四喜,文飞球.植入综合征[J].中国小儿急救医学,2022,29(8):573-576.DOI:10.3760/cma.j.issn.1673-4912.2022.08.001.
[11] Khandelwal P, Mellor-Heineke S, Rehman N, et al. Cytokine profile of engraftment syndrome in pediatric hematopoietic stem cell transplant recipients[J]. Biol Blood Marrow Transplant, 2016, 22(4):690-697. DOI: 10.1016/j.bbmt.2015.12.016.
[12] Haga Y, Ogawa M. Neutrophil elastase inhibitor (ONO-5046.Na) decreases production of proinflammatory cytokines by lipopolysaccharide-stimulated human monocytes[J]. Res Commun Mol Pathol Pharmacol, 1997, 98(3):243-248.
[13] 刘芳.异基因脐血移植治疗儿童血液病预处理方案优化的临床研究[D].北京:北京协和医学院,2021.
[14] 中国医师协会儿童重症医师分会.西维来司他钠在儿童重症医学科应用专家共识[J].中国实用儿科杂志,2023,38(5):321-326.DOI:10.19538/j.ek2023050601.
[15] Penack O, Marchetti M, Ruutu T, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation[J]. Lancet Haematol, 2020, 7(2):e157-e167. DOI: 10.1016/S2352-3026(19)30256-X.
|
